Stimulation of the brain NO/cyclic GMP pathway by peripheral administration of tetrahydrobiopterin in the hph-1 mouse

Journal of Neurochemistry

Volumn 73, Issue 6, 1999, Pages 2563-2568

  Canevari, Laura ^a,b   Land, John M ^a   Clark, John B ^a   Heales, Simon J R ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cyclic GMP; Dopa responsive dystonia; GTP cyclohydrolase deficiency; hph 1 mouse; Nitric oxide synthase; Tetrahydrobiopterin

Indexed keywords

CYCLIC GMP; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DYSTONIA; ENZYME ACTIVITY; ENZYME DEFICIENCY; MONOAMINE METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBSTITUTION THERAPY;

ANIMALS; BIOPTERIN; BRAIN; CEREBELLUM; CYCLIC GMP; DYSTONIC DISORDERS; GTP CYCLOHYDROLASE; MICE; MICE, NEUROLOGIC MUTANTS; NERVE TISSUE PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PROSENCEPHALON; SECOND MESSENGER SYSTEMS; SEROTONIN; STIMULATION, CHEMICAL;

ANIMALIA;

EID: 0032727867     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0732563.x     Document Type: Article

References (38)

1. Barker J. E., Strangward H. M., Brand M. P., Hurst R. D., Land J. M., Clark J. B., and Heales S. J. (1998) Increased inducible nitric oxide synthase protein but limited nitric oxide formation occurs in astrocytes of the hph-1 (tetrahydrobiopterin deficient) mouse. Brain Res. 804, 1-6.
2. Blau N., Thöni B., Heizmann C. W., and Dhondt J.-L. (1993) Tetrahydrobiopterin deficiency: from phenotype to genotype. Pteridines 4, 1-10.
3. Brand M. P., Heales S. J., Land J. M., and Clark J. B. (1995) Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the hph-1 mouse. J. Inherit. Metab. Dis. 18, 33-39.
4. Brand M. P., Briddon A., Land J. M., Clark J. B., and Heales S. J. R. (1996a) Impairment of the nitric oxide/cyclic GMP pathway in cerebellar slices prepared from the hph-1 mouse. Brain Res. 735, 169-172.
5. Brand M. P., Hyland K., Engle T., Smith I., and Heales S. J. R. (1996b) Neurochemical effects following peripheral administration of tetrahydropterin derivatives to the hph-1 mouse. J. Neurochem. 66, 1150-1156.
6. Deonna T. (1986) DOPA-sensitive progressive dystonia of childhood with fluctuations of symptoms - Segawa's syndrome and possible variants. Results of a collaborative study of the European Federation of Child Neurology Societies (EFCNS). Neuropediatrics 17, 81-85.
7. Endres W. (1985) Therapy of tetrahydrobiopterin deficiencies, in Inherited Diseases of Amino Acid Metabolism (Bickel H. and Wachtel U., eds), pp. 124-132. Thieme, Stuttgart.
8. Fink J. K., Ravin P., Argoff C. E., Levine R. A., Brady R. O., Hallett M., and Barton N. W. (1989) Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variation. Neurology 39, 1393-1395.
9. Furukawa Y., Shimadzu M., Rajput A. H., Shimizu Y., Tagawa T., Mori H., Yokochi M., Narabayashi H., Hornykiewicz O., Mizuno Y., and Kish S. J. (1996) GTP-cyclohydrolase I gene mutations in hereditary progressive and dopa-responsive dystonia. Ann. Neurol. 39, 609-617.
10. Furukawa Y., Kish S. J., Bebin E. M., Jacobson R. D., Fryburg J. S., Wilson W. G., Shimadzu M., Hyland K., and Trugman J. M. (1998a) Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations. Ann. Neurol 44, 10-16.
11. Furukawa Y., Lang A. E., Trugman J. M., Bird T. D., Hunter A., Sadeh M., Tagawa T., St. George-Hyslop P. H., Guttman M., Morris L. W., Hornykiewicz O., Shimadzu M., and Kish S. J. (1998b) Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology 50, 1015-1020.
12. Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14, 60-67.
13. Garthwaite J. and Boulton C. L. (1995) Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57, 683-706.
14. Gütlich M., Ziegler I., Witter K., Hemmens B., Hühner L., McDonald J. D., Werner T., Rödl W., and Bacher A. (1994) Molecular characterization of HPH-1: a mouse mutant deficient in GTP cyclohydrolase 1 activity. Biochem. Biophys. Res. Commun. 203, 1675-1681.
15. Heales S. J. R., Canevari L., Brand M. P., Clark J. B., Land J. M., and Hyland K. (1999) Cerebrospinal fluid nitrite plus nitrate correlates with tetrahydrobiopterin concentration. J. Inherit. Metab. Dis. 22, 221-223.
16. Howells D. W., Smith I., and Hyland K. (1986) Estimation of tetrahydrobiopterin and other pterins in cerebrospinal fluid using reversed-phase high-performance liquid chromatography with electrochemical and fluorescence detection. J. Chromatogr. 381, 285-294.
17. Hyland K., Surtees R. A., Heales S. J., Bowron A., Howells D. W., and Smith I. (1993) Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population. Pediatr. Res. 34, 10-14.
18. Hyland K., Gunasekera R. S., Engle T., and Arnold L. A. (1996) Tetrahydrobiopterin and biogenic amine metabolism in the hph-1 mouse. J. Neurochem. 67, 752-759.
19. Ignarro L. J. (1990) Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacol. Toxicol. 67, 1-7.
20. Kapatos G. and Kaufman S. (1981) Peripherally administered reduced pterins do enter the brain. Science 212, 955-956.
21. Kaufman S. (1978) Establishment of tetrahydrobiopterin as the hydroxylase cofactor and a review of some recent studies in man. Psychopharmacol. Bull. 14, 38-40.
22. Kaufman S., Kapatos G., McInnes R. R., Schulman J. D., and Rizzo W. B. (1982) Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain. Pediatrics 70, 376-380.
23. Klatt P., Schmid M., Leopold E., Schmidt K., Werner E. R., and Mayer B. (1994) The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, and allosteric interaction with the substrate domain. J. Biol. Chem. 269, 13861-13866.
24. Lorden J. F., Oltmans G. A., McKeon T. W., Lutes J., and Beales M. (1985) Decreased cerebellar 3′,5′-cyclic guanosine monophosphate levels and insensitivity to harmaline in the genetically dystonic rat (dt). J. Neurosci. 5, 2618-2625.
25. Lowry O. H., Rosebrough N. J., Fair A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
26. Mayer B. and Werner E. R. (1995) Why tetrahydrobiopterin? Adv. Pharmacol. 34, 251-261.
27. McDonald J. D., Cotton R. G., Jennings I., Ledley F. D., Woo S. L., and Bode V. C. (1988) Biochemical defect of the hph-1 mouse mutant is a deficiency in GTP-cyclohydrolase activity. J. Neurochem. 50, 655-657.
28. McInnes R. R., Kaufman S., Warsh J. J., Van Loon G. R., Milstien S., Kapatos G., Soldin S., Walsh P., MacGregor D., and Hanley W. B. (1984) Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin. J. Clin. Invest. 73, 458-469.
29. Miller L., Insel T., Scheinin M., Aloi J., Murphy D. L., Linnoila M., and Lovenberg W. (1986) Tetrahydrobiopterin administration to rhesus macaques. Its appearance in CSF and effect on neurotransmitter synthesis. Neurochem. Res. 11, 291-298.
30. Niederwieser A., Curtius H. C., Wang M., and Leupold D. (1982) Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man. Eur. J. Pediatr. 138, 110-112.
31. Niederwieser A., Blau N., Wang M., Joller P., Atares M., and Cardesa-Garcia J. (1984) GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur. J. Pediatr. 141, 208-214.
32. Nygaard T. G., Marsden C. D., and Duvoisin R. C. (1988) Dopa-responsive dystonia. Adv. Neurol. 50, 377-384.
33. Nygaard T. G., Waran S. P., Levine R. A., Naini A. B., and Chutorian A. M. (1994) Dopa-responsive dystonia simulating cerebral palsy. Pediatr. Neurol. 11, 236-240.
34. Shimoji M., Hirayama K., Hyland K., and Kapatos G. (1999) GTP cyclohydrolase I gene expression in the brains of male and female hph-1 mice. J. Neurochem. 72, 757-764.
35. 4 deficiency). Eur. J. Pediatr. 148, 450-452.
36. 4 monotherapy. Pteridines 5, 46-47.
37. Tayeh M. A. and Marietta M. A. (1989) Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J. Biol. Chem. 264, 19654-19658.
38. Zar J. H. (1996) Simple linear correlation, in Biostatistical Analysis, 3rd edit., pp. 371-406. Prentice Hall, Upper Saddle River, New Jersey.